Koji Azuma
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Impact of preexisting interstitial lung disease on pneumonitis and survival during first-line immune checkpoint inhibitor-based therapy in non-small cell lung cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 08, 2026
Systemic Inflammation Modifies the Efficacy of Bevacizumab Added to Atezolizumab Plus Chemotherapy for Advanced Non-Squamous Non-Small Cell Lung Cancer: A Multicenter Retrospective Study.
Journal: Thoracic cancer
Published: January 31, 2026
Impact of pre-existing interstitial lung abnormalities on pneumonitis risk and survival in chemo-naive patients with non-small-cell lung cancer receiving pembrolizumab plus chemotherapy.
Journal: Respiratory medicine
Published: December 24, 2025
Corrigendum to "Timing of first pembrolizumab infusion and long-term outcomes in non-small cell lung cancer: A retrospective multicenter study" [Eur J Cancer. 2025;228:115748].
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 04, 2025
Timing of first pembrolizumab infusion and long-term outcomes in non-small cell lung cancer: A retrospective multicenter study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 19, 2025
Linear-Optical Fusion Boosted by High-Dimensional Entanglement.
Journal: Physical review letters
Published: July 19, 2024
Organizing Pneumonia With Diffuse Alveolar Hemorrhage Induced by the Kampo Medicine Choreito.
Journal: Journal of medical cases
Published: April 09, 2024
Synchronous Double Primary Lung Adenocarcinomas With EGFR L858R Point Mutation and MET Exon 14 Skipping Mutation.
Journal: Journal of medical cases
Published: March 30, 2024
Disseminated non-tuberculous mycobacterial infection caused by Mycobacterium obuense in an immunocompromised patient: a case report.
Journal: BMC infectious diseases
Published: June 07, 2023
Correction to: Nivolumab treatment beyond progressive disease in advanced non‑small cell lung cancer.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: February 22, 2022
Limitations of End-Tidal CO2 Measured with a Portable Capnometer to Estimate PaCO2 for Patients with Respiratory Disease.
Journal: Turkish thoracic journal
Published: February 03, 2022
Retrospective analysis of long-term survival factors in patients with advanced non-small cell lung cancer treated with nivolumab.
Journal: Thoracic cancer
Published: November 28, 2021
Last Updated: 09/26/2026